Seclidemstat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Seclidemstat, covering 2023-08-01 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]